AAPM medical physics practice guideline 13.a: HDR brachytherapy, part A-49F3AC20

The goal of this report is to assist the clinical medical physicist in assuring that key quality metrics and practice considerations are met to ensure the safe, reliable, and reproducible application of high-dose rate (HDR) brachytherapy. This guideline has been developed to provide appropriate minimum standards for such services. The secondary goal is to provide recommendations to the regulatory community from the experts on this practice guideline to guide the adoption of regulations in the future. This MPPG is limited to iridium-192-based HDR brachytherapy and will not discuss electronic, low-dose rate, pulsed dose rate brachytherapy, or any alternative radionuclides.